Australia markets closed

CureVac N.V. (5CV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
13.81+0.79 (+6.10%)
At close: 05:20PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.47B
Enterprise value 1.84B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)21.03
Price/book (mrq)3.69
Enterprise value/revenue 15.71
Enterprise value/EBITDA -6.47

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-75.54%
S&P500 52-week change 3-11.93%
52-week high 364.07
52-week low 312.35
50-day moving average 315.32
200-day moving average 323.95

Share statistics

Avg vol (3-month) 36.16k
Avg vol (10-day) 33.11k
Shares outstanding 5187.12M
Implied shares outstanding 6N/A
Float 884.4M
% held by insiders 152.57%
% held by institutions 124.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin -266.86%
Operating margin (ttm)-822.89%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)-45.17%

Income statement

Revenue (ttm)117.33M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)143.00%
Gross profit (ttm)-135.09M
EBITDA -953.85M
Net income avi to common (ttm)-313.11M
Diluted EPS (ttm)-1.68
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)658.2M
Total cash per share (mrq)3.52
Total debt (mrq)40.66M
Total debt/equity (mrq)6.03
Current ratio (mrq)3.32
Book value per share (mrq)3.61

Cash flow statement

Operating cash flow (ttm)-673.13M
Levered free cash flow (ttm)N/A